CYCLOSPORINE THERAPY AND THE DEVELOPMENT OF INTERSTITIAL FIBROSIS IN RENAL-ALLOGRAFTS

被引：0
|
作者：
RUIZ, P
KOLBECK, PC
SCROGGS, MW
BOLLINGER, RR
SANFILIPPO, F
机构：
[1] DUKE UNIV,DEPT PATHOL,BOX 3712,DURHAM,NC 27710
[2] DUKE UNIV,DEPT SURG,DURHAM,NC 27710
[3] VET ADM MED CTR,DURHAM,NC 27705
来源：
TRANSPLANTATION PROCEEDINGS | 1988年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：807 / 811
页数：5
相关论文
共 50 条
  • [31] CONTAMINATED RENAL-ALLOGRAFTS
    BORE, PJ
    BASU, PK
    RUDGE, CJ
    SELLS, RA
    ARCHIVES OF SURGERY, 1980, 115 (06) : 755 - 756
  • [32] STUDIES ON MORPHOLOGICAL OUTCOME OF CYCLOSPORINE-ASSOCIATED ARTERIOLOPATHY AFTER DISCONTINUATION OF CYCLOSPORINE IN RENAL-ALLOGRAFTS
    MOROZUMI, K
    THIEL, G
    ALBERT, FW
    BANFI, G
    GUDAT, F
    MIHATSCH, MJ
    CLINICAL NEPHROLOGY, 1992, 38 (01) : 1 - 8
  • [33] GLOMERULAR THROMBI IN RENAL-ALLOGRAFTS ASSOCIATED WITH CYCLOSPORIN THERAPY
    NEILD, G
    REUBEN, R
    HARTLEY, B
    CAMERON, JS
    KIDNEY INTERNATIONAL, 1985, 27 (01) : 345 - 345
  • [34] POSTOPERATIVE RADIONUCLIDE MONITORING OF RENAL-ALLOGRAFTS ON TRIPLE THERAPY
    THOMSEN, HS
    LOKKEGAARD, H
    NIELSEN, SL
    LARSEN, S
    DANISH MEDICAL BULLETIN, 1988, 35 (04): : 395 - 397
  • [35] The influence of tubular phenotypic changes on the development of diffuse interstitial fibrosis in renal allografts
    Ozdemir, B. Handan
    Haberal, Nihan
    Ozdemir, F. Nurhan
    Demirhan, Beyhan
    Haberal, Mehmet
    VIRCHOWS ARCHIV, 2007, 451 (02) : 512 - 512
  • [36] The influence of tubular phenotypic changes on the development of diffuse interstitial fibrosis in renal allografts
    Ozdemir, Handan B.
    Haberal, Nihan
    Ozdemir, Nurhan F.
    Demirhan, Beyhan
    Haberal, Mehmet
    TRANSPLANT INTERNATIONAL, 2007, 20 : 10 - 11
  • [37] The Influence of Tubular Phenotypic Changes on the Development of Diffuse Interstitial Fibrosis in Renal Allografts
    Ozdemir, B. H.
    Ozdemir, A. A.
    Colak, T.
    Sezer, S.
    Haberal, M.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (02) : 527 - 529
  • [38] LOW-DOSE CYCLOSPORINE IS SAFE IN RENAL-ALLOGRAFTS WITH PREEXISTING PARENCHYMAL DAMAGE
    LUSTIG, S
    YUSSIM, A
    SHAHARABANI, E
    NAKACHE, R
    SHMUELI, D
    BARNATHAN, N
    BONER, G
    SHAPIRA, Z
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1001 - 1002
  • [39] ASSOCIATIONS BETWEEN CYCLOSPORINE THERAPY AND INTERSTITIAL FIBROSIS IN RENAL-ALLOGRAFT BIOPSIES
    RUIZ, P
    KOLBECK, PC
    SCROGGS, MW
    SANFILIPPO, F
    TRANSPLANTATION, 1988, 45 (01) : 91 - 95
  • [40] 10-YEAR EXPERIENCE WITH CYCLOSPORINE AS PRIMARY IMMUNOSUPPRESSION IN RECIPIENTS OF RENAL-ALLOGRAFTS
    TILNEY, NL
    CHANG, A
    MILFORD, EL
    WHITLEY, WD
    LAZARUS, JM
    RAMOS, EL
    STROM, TB
    CARPENTER, CB
    KIRKMAN, RL
    ANNALS OF SURGERY, 1991, 214 (01) : 42 - 49
12345